(Q41721087)

8 October 2017

title

A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease (English)

1 reference

gastroesophageal reflux disease

8 October 2017

main subject

0 references

author name string

Gerson LB

1

1 reference

8 October 2017

Robbins AS

2

1 reference

8 October 2017

Garber A

3

1 reference

8 October 2017

Hornberger J

4

1 reference

8 October 2017

Triadafilopoulos G

5

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

The American Journal of Gastroenterology

8 October 2017

published in

1 reference

8 October 2017

volume

95

1 reference

8 October 2017

issue

2

1 reference

8 October 2017

page(s)

395-407

1 reference

The impact of gastroesophageal reflux disease on health-related quality of life.

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.01759.X

Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.01759.X

The long term results of open antireflux surgery in a community-based health care center

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.01759.X

Cost and Quality Effects of Alternative Treatments for Persistent Gastroesophageal Reflux Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.01759.X

Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.01759.X

Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.01759.X

Outcome of erosive reflux esophagitis after Nissen fundoplication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.01759.X

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.01759.X

10.1111/J.1572-0241.2000.01759.X

21 January 2018

Identifiers

DOI

1 reference

8 October 2017

1 reference